A carregar...
Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
The recent introduction of direct oral anticoagulants, including rivaroxaban, dabigatran, apixaban, and edoxaban, for the acute treatment and secondary prevention of venous thromboembolism and in atrial fibrillation has been shown to provide greater clinical benefit than oral vitamin K antagonists....
Na minha lista:
| Publicado no: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768245/ https://ncbi.nlm.nih.gov/pubmed/29348918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17753336 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|